Basic Information
PHOXILIUM 1.2 MMOL/L PHOSPHATE SOLUTION FOR HAEMODIALYSIS/HAEMOFILTRATION
SOLUTION, STERILE
Regulatory Information
SIN15730P
June 27, 2019
Prescription Only
Therapeutic
INTRAVENOUS
August 10, 2023
May 30, 2025
XB05ZB
Company Information
Active Ingredients
Strength: 2.440 g/L
Strength: 6.435 g/L
Strength: 3.675g/L
Strength: 0.225 g/L
Strength: 2.918 g/L
Strength: 0.314 g/L
Detailed Information
Contraindications
**4.3 Contraindications** Hypersensitivity to the active substance(s) or to any of the excipients listed in section 6.1 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_. Solution dependent contraindications - Hyperkalaemia - Metabolic alkalosis - Hyperphosphataemia Haemofiltration/- dialysis dependent contraindications - Renal failure with pronounced hypercatabolism, if the uraemic symptoms cannot be corrected with haemofiltration or haemodiafiltration, - Insufficient arterial pressure in the vascular access, - Systemic anticoagulation if there is a high risk of haemorrhage.
Indication Information
**4.1 Therapeutic indications** PHOXILIUM solution is used for CRRT (Continuous Renal Replacement Therapy) in critically ill patients with ARF (Acute Renal Failure) when pH and kalaemia have been restored to normal and when the patients need phosphate supplementation for loss of phosphate in the ultrafiltrate or to the dialysate during CRRT. PHOXILIUM solution may also be used in cases of drug poisoning or intoxications when the poisons are dialyzable or pass through the membrane. PHOXILIUM solution is indicated for use in patients with normal kalaemia and normal or hypophosphataemia.